The role of CD8+ T-cell response in HIV infection
- PMID: 15332430
The role of CD8+ T-cell response in HIV infection
Abstract
CD8+ T-cells with cytotoxic (CTL) activity play a pivotal role in controlling viral infections. Although most patients chronically infected with HIV have CTL response against the virus, for reasons that are not well understood this response is not able to successfully control viral replication. The crucial role of this type of response has been clearly demonstrated in the setting of acute infection using the simian model of AIDS, in which a strong CTL response develops, supporting its role in humans. This approach has been possible due to the development of new assays to quantify CTL activity with great sensitivity and specificity. The interaction of CTL response and HIV during this acute stage of infection is crucial, since it most probably determines the viral set-point and thus the rate of HIV disease progression. In the setting of chronic HIV infection, the use of tetrameric complexes and IFN-gamma production assays have made it possible to investigate the different functional aspects of these cells and have also facilitated the evaluation of this response in large patient populations. Defects in cytokine production and in perforin expression have been found, as well as alterations in phenotypic maturation and a low proliferation of these cells. All these findings have been cited to explain the inability of CTLs to efficiently control virus replication. Nonetheless, accumulating evidence points toward an important role for CTL response in the partial containment of HIV replication in chronic infection. An especially strong support for this observation derives from studies analyzing the selective pressure exerted by the immune response over viral evolution. Very recently, longitudinal and cross-sectional studies in large populations of patients have demonstrated that viral evolution is in part driven by HIV-specific T-cell responses.
Similar articles
-
CD8 lymphocytes in HIV infection: helpful and harmful.J Clin Lab Immunol. 1997;49(1):15-32. J Clin Lab Immunol. 1997. PMID: 9819670 Review.
-
Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.Chin Med J (Engl). 2006 Dec 5;119(23):1949-57. Chin Med J (Engl). 2006. PMID: 17199938
-
Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape.Stem Cells. 2000;18(4):230-44. doi: 10.1634/stemcells.18-4-230. Stem Cells. 2000. PMID: 10924089 Review.
-
Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.APMIS. 2007 Jun;115(6):757-68. doi: 10.1111/j.1600-0463.2007.apm_595.x. APMIS. 2007. PMID: 17550385
-
Inhibition of HIV-1-specific T-cells and increase of viral load during immunosuppressive treatment in an HIV-1 infected patient with Chlamydia trachomatis induced arthritis.J Clin Virol. 2005 Nov;34(3):224-30. doi: 10.1016/j.jcv.2005.07.006. Epub 2005 Sep 2. J Clin Virol. 2005. PMID: 16140574
Cited by
-
The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model.J Virol. 2022 Dec 21;96(24):e0173022. doi: 10.1128/jvi.01730-22. Epub 2022 Nov 30. J Virol. 2022. PMID: 36448802 Free PMC article.
-
HIV-specific CD8+ T cells from elite controllers are primed for survival.J Virol. 2013 May;87(9):5170-81. doi: 10.1128/JVI.02379-12. Epub 2013 Feb 28. J Virol. 2013. PMID: 23449791 Free PMC article.
-
Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals.Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3390-5. doi: 10.1073/pnas.0611423104. Epub 2007 Feb 21. Proc Natl Acad Sci U S A. 2007. PMID: 17360656 Free PMC article.
-
Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview.Front Microbiol. 2016 Jan 12;6:1444. doi: 10.3389/fmicb.2015.01444. eCollection 2015. Front Microbiol. 2016. PMID: 26793166 Free PMC article. Review.
-
Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression.J Virol. 2006 Jan;80(1):236-45. doi: 10.1128/JVI.80.1.236-245.2006. J Virol. 2006. PMID: 16352548 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials